Home / Authors
Co-founder and CEO, Animi
Executive Board Member, Alexithymia Research International Alliance
Fellow, Sigma Squared Society
Bolek writes Animi's educational content on alexithymia, emotional awareness, and practical emotional health tools designed to help people build emotional understanding in an understandable, usable, and structured way.
Bolek Kerous co-founded and currently leads Animi Public Benefit Corporation, a company focused specifically on improving alexithymia, emotional awareness, and emotional intelligence. His work sits at the intersection of product development, psychoeducation, and academic research translation: taking what the literature says and turning it into tools and learning experiences that people can actually use.
He serves on the executive board of the Alexithymia Research International Alliance, an organization dedicated to improving methods and practices in alexithymia research. He is also a fellow of Sigma Squared Society, a nonprofit global community of ambitious young founders selected for impact-driven initiatives and their ability to transform broken industries.
The combination of product leadership, research affiliation, and mission focus gives him a practical and domain-specific perspective on the topic rather than a generic wellness lens.
Bolek's motivation to work on alexithymia is also very much personal. He struggled with alexithymia himself and found that improvement took sustained trial and error, self-experimentation, and a lot of time spent figuring out what actually works.
Animi grew out of the realization that many other people were dealing with the same problem, and that better tools were possible and could help people improve faster without repeating the same mistakes. That firsthand experience and many conversations with other alexithymics inform the way Animi approaches education and product design: making emotional awareness more concrete, learnable, and measurable.
Animi's educational content is grounded in published research, while also incorporating first-hand lived experience and community feedback, as well as practical product experience, and an editorial process designed to keep claims specific and accountable. Most content is also reviewed by the Animi research team before publication or update.
This content is informational and educational. It is not a substitute for individualized medical advice, diagnosis, or treatment.
